| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.9B | $13.7B | $14.4B | $16.3B | $17.7B | $19.6B | $20.8B | $24.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.3B | $1.2B | $1.4B | $1.4B | $2.1B | $2.0B | $2.0B | $2.0B |
| Operating Income | $1.0B | $1.0B | $1.2B | $1.4B | $1.1B | $2.1B | $3.3B | $3.5B |
| Net Income | $0.4B | $0.1B | $-0.6B | $0.7B | $-0.1B | $-5.4B | $1.3B | $1.8B |
| EPS (Basic) | $2.15 | $0.46 | $-2.48 | $2.87 | $-0.59 | $-20.76 | $4.53 | $6.15 |
| EPS (Diluted) | $2.10 | $0.46 | $-2.48 | $2.81 | $-0.59 | $-20.76 | $4.47 | $6.04 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.2B | $13.9B | $15.8B | $20.1B | $22.0B | $26.0B | $29.6B | $33.9B |
| Current Assets | $5.4B | $5.1B | $6.1B | $7.4B | $8.2B | $9.0B | $9.1B | $9.6B |
| Cash & Equivalents | $1.8B | $1.2B | $1.9B | $2.7B | $3.0B | $3.7B | $2.9B | $2.6B |
| Total Liabilities | $9.7B | $10.8B | $12.0B | $14.8B | $16.7B | $20.9B | $17.8B | $20.1B |
| Current Liabilities | $4.4B | $4.4B | $5.2B | $6.9B | $8.2B | $7.9B | $9.5B | $9.9B |
| Stockholders' Equity | $3.2B | $2.8B | $3.5B | $5.1B | $5.0B | $4.8B | $11.4B | $13.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.4B | $1.4B | $1.5B | $0.1B | $2.4B | $1.8B | $3.2B |
| Investing Cash Flow | $-0.5B | $-0.5B | $-0.6B | $-0.1B | $4.7B | $-2.1B | $0.1B | $-0.0B |
| Capital Expenditures | $0.2B | $0.2B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B |
| Financing Cash Flow | $-0.3B | $-1.5B | $-1.5B | $-1.8B | $-5.5B | $0.7B | $-1.7B | $-1.9B |